T0	Participants 70 120	for moderate to severe facial erythema of rosacea:
T1	Participants 193 223	BACKGROUND Erythema of rosacea
T2	Participants 577 686	In study A, 122 subjects were randomized to receive a single application of BT 0·07%, 0·18%, 0·5% or vehicle.
T3	Participants 687 751	In study B (4-week treatment and 4-week follow-up), 269 subjects
T4	Participants 1821 1861	treatment of moderate to severe erythema